Hum Reprod:不孕问题相关检查和随后转诊 全科医师指南依从性如何

2017-06-26 顾歆纯 环球医学资讯

现如今,不孕不育的女性越来越多。2017年6月,发表在《Hum Reprod.》的一项研究调查了全科医师(GPs)对不孕患者检查和随后从初级到二级医疗转诊指南的依从性。

现如今,不孕不育的女性越来越多。2017年6月,发表在《Hum Reprod.》的一项研究调查了全科医师(GPs)对不孕患者检查和随后从初级到二级医疗转诊指南的依从性。

研究问题:GPs对不孕患者检查和随后从初级到二级医疗转诊指南的依从性如何?

总结回答:GPs对不孕患者的指南依从性涉及9.2%的不孕患者。

已知信息:对转诊推荐的依从性较好可以降低不必要的转诊、诊断和治疗,同时也可以降低医疗花费。此外,也可以省去患者不必要的求医麻烦,减轻精神负担,节约医疗成本。

研究设计、样本大小和持续时间:对2011 年1月至2013年6月期间,306例从初级医疗转诊到拥有IVF设备的二级医疗教学医院或三级医院的进行基本生育检查的患者进行回顾性队列研究。

受试者/材料、地点和方法:符合纳入标准的夫妇为:曾经没有因为不孕问题转诊且打算要孩子意愿的持续时间<2年。从转诊函和病历记录中收集评价指南依从性的数据。使用患者调查问卷,考察患者的一般特性和生育相关特征。

主要结果和可能性的影响:GP按照推荐进行衣原体抗体滴度(CAT)测试和精液分析的转诊患者比例分别是15.9%和42.2%。根据指南,39%的夫妇计划转诊(即,根据指南不需要立即转诊),8.8%为不必要的转诊。分别有80.0%和57.1%的病例在二级医疗中不必要重复进行CAT和精液分析。

局限性:研究者没有纳入初级医疗中期待治疗的非转诊患者,在这一时期,此类患者怀孕的情况不清楚。这可能会造成对初级医疗作用的低估。

结果的广泛影响:该研究结果显示,涉及不孕问题相关检查和随后转诊的指南依从性较低。患者转诊需求的影响尚不清楚。应该考察指南依从性的障碍和促进因素,以开发用来改善不孕治疗中检查和转诊领域指南依从性的干预,减少二级医疗中不必要的检查。

竞争利益:无。

原始出处:

van der Pluijm-Schouten, H. W., et al.General practitioners' adherence to work-up and referral recommendations in fertility care.Hum Reprod. 2017 Jun 1;32(6):1249-1257. doi: 10.1093/humrep/dex060.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1648594, encodeId=9e151648594e5, content=<a href='/topic/show?id=afa493462ec' target=_blank style='color:#2F92EE;'>#转诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93462, encryptionId=afa493462ec, topicName=转诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Mar 22 03:14:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946588, encodeId=e963194658883, content=<a href='/topic/show?id=7c2c295853c' target=_blank style='color:#2F92EE;'>#全科医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29585, encryptionId=7c2c295853c, topicName=全科医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Fri Nov 03 02:14:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319283, encodeId=f33f131928340, content=<a href='/topic/show?id=60172686668' target=_blank style='color:#2F92EE;'>#依从性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26866, encryptionId=60172686668, topicName=依从性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Wed Jun 28 10:14:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601879, encodeId=b99916018e9ab, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Wed Jun 28 10:14:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1648594, encodeId=9e151648594e5, content=<a href='/topic/show?id=afa493462ec' target=_blank style='color:#2F92EE;'>#转诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93462, encryptionId=afa493462ec, topicName=转诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Mar 22 03:14:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946588, encodeId=e963194658883, content=<a href='/topic/show?id=7c2c295853c' target=_blank style='color:#2F92EE;'>#全科医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29585, encryptionId=7c2c295853c, topicName=全科医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Fri Nov 03 02:14:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319283, encodeId=f33f131928340, content=<a href='/topic/show?id=60172686668' target=_blank style='color:#2F92EE;'>#依从性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26866, encryptionId=60172686668, topicName=依从性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Wed Jun 28 10:14:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601879, encodeId=b99916018e9ab, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Wed Jun 28 10:14:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1648594, encodeId=9e151648594e5, content=<a href='/topic/show?id=afa493462ec' target=_blank style='color:#2F92EE;'>#转诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93462, encryptionId=afa493462ec, topicName=转诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Mar 22 03:14:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946588, encodeId=e963194658883, content=<a href='/topic/show?id=7c2c295853c' target=_blank style='color:#2F92EE;'>#全科医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29585, encryptionId=7c2c295853c, topicName=全科医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Fri Nov 03 02:14:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319283, encodeId=f33f131928340, content=<a href='/topic/show?id=60172686668' target=_blank style='color:#2F92EE;'>#依从性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26866, encryptionId=60172686668, topicName=依从性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Wed Jun 28 10:14:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601879, encodeId=b99916018e9ab, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Wed Jun 28 10:14:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]
    2017-06-28 fyxzlh
  4. [GetPortalCommentsPageByObjectIdResponse(id=1648594, encodeId=9e151648594e5, content=<a href='/topic/show?id=afa493462ec' target=_blank style='color:#2F92EE;'>#转诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93462, encryptionId=afa493462ec, topicName=转诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Mar 22 03:14:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946588, encodeId=e963194658883, content=<a href='/topic/show?id=7c2c295853c' target=_blank style='color:#2F92EE;'>#全科医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29585, encryptionId=7c2c295853c, topicName=全科医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Fri Nov 03 02:14:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319283, encodeId=f33f131928340, content=<a href='/topic/show?id=60172686668' target=_blank style='color:#2F92EE;'>#依从性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26866, encryptionId=60172686668, topicName=依从性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Wed Jun 28 10:14:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601879, encodeId=b99916018e9ab, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Wed Jun 28 10:14:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]
    2017-06-28 sunylz

相关资讯

Sci Rep:女性不明原因的不孕不育,可能与基因突变有关

至今仍有大约10-15%的不孕不育症患者和50%的复发性流产妇女的病理不明。本文的通讯作者,贝勒医学院妇产科分子和人类遗传学教授,贝勒和德克萨斯儿童医院产前遗传学临床主任Ignatia B. Van den Veyver说,研究人员已经发现了NLRP家族一些基因的功能缺失会导致诸如异常胎盘发育、着床前流产、以及极少数的胎儿发育障碍等失败妊娠。文章的第一作者,Van den Veyver实验室的一名

NEJM:40%的不孕女性或不用做试管婴儿,已经100岁的子宫输卵管造影术也可解决问题

日前,一条新闻刷屏了外国大小媒体!科学家在《新英格兰医学杂志》上发表研究,一个已经100岁的影像学检查技术在新的研究中帮助将近40%的不孕女性成功怀孕!根据研究人员的总结,这意味着这种简单的检查可以为夫妻们提供成功受孕的机会,而不再仅仅依靠又贵又损伤身体的试管婴儿。是什么技术如此厉害?它就是子宫输卵管造影术(hysterosalpingography,HSG)。HSG是一种经X射线的造影检查,在1

Hum Reprod Update:无排卵性PCOS患者不孕管理指南推荐

美国生殖医学中心人员对提交给世卫组织(WHO)的询证指南进行了总结,描述了指南的方法,以综述的形式阐明了对女性多囊卵巢综合征(PCOS)导致的无排卵性不孕的管理。提供支持指南的证据包括的合作过程:1.识别首要问题和关键结局,2.检索最新的证据和现有的指南,3.评估和综合证据,4.制定指南草案达成在全球范围内相关人员的共识。每个指南推荐都进行了质量评估,使用极低、低、中或高质量进行分级。综合证据后在

NEJM:多囊卵巢综合征不孕女性选择新鲜胚胎还是冷冻胚胎?

一般情况下,对于体外受精(IVF),新鲜胚胎移植优于冷冻胚胎移植,但有证据表明,在多囊卵巢综合征的女性中,冷冻胚胎移植可提高活产率,降低卵巢过度刺激综合征和妊娠并发症的发生率。原始出处:Zi-Jiang Chen,Yuhua Shi,Yun Sun,et al.Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary S

高泌乳素血症是怎么导致的不孕?

有时候,有的女性发现自己不怀孕,经过检查才发现原来是得了高泌乳素血症。如何诊治高PRL血症导致的不孕?1.泌乳素在正常非哺乳期水平很低泌乳素是垂体分泌的一种激素,正常情况下在非哺乳期时,泌乳素维持在一个非常低的水平,非哺乳期的女性也不会有泌乳或溢乳的症状。我们知道催乳(激)素(prolactin,PRL)其主要功能为促进泌乳。从妊娠7周开始增多,随妊娠进展逐渐增量,妊娠足月分娩前达高峰,约200μ

Hum Reprod:不孕夫妇生育相关生活质量调查

根据两个随机对照试验的调查结果,多囊卵巢综合征妇女其生育相关生活质量评分明显低于对不明原因的不孕妇女。来自科罗拉多大学丹佛分校的Nanette Santor博士和同事对773名女性和641名男性参与的PPCOS II研究和865名女性和849名男性参加的AMIGOS研究数据进行了分析。这两项试验中的参与者完成了生育能力相关的生活质量调查,旨在评估在男性和女性不孕不育的负担。研究人员评估了不同诊断(